Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Mike S. Newton, CIM FCSILife Technologies CorporationLIFEPAST TOP PICKSep 27, 2010

(A Top Pick Oct 27/09. Up 0.83%.) Got stopped out. Still a good buy.
$47.62

Stock price when the opinion was issued

$15.61

As of Jun 12, 2026. Market Open.

biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

PAST TOP PICK

(Top Pick Sep 13/11, Up 26.05%) Continues to do well. Still loves it.

PAST TOP PICK

(A Top Pick Sept 13/11. Up 19.62%.) Biotechnology, biopharmaceutical. Currently they are doing a DNA sequencing kit that is under $1000 and takes 2 weeks. Has considerable cash flow and great metrics. Wouldn’t be surprised if it got taken out by a private equity firm.

PAST TOP PICK
(A Top Pick Sept 13/11. Up 23.96%.) Came out in January with a very cheap product that does DNA sequencing. Continues to be a name that is suggested as a takeout candidate.
TOP PICK
Owned in the past and it did him very well. One of the best and largest life sciences in the S&P 500. Once of the best assets in that space. A similar company was bought for a 40% premium. Government safety program, diagnostic equipment.
TOP PICK
Trades at only 10 times earnings. Largest life sciences in S&P 500. Nice looking chart. In 90% of all lab work, from forensic to agricultural. High growth profile that is just starting to take off. Excellent earnings.